XML 75 R59.htm IDEA: XBRL DOCUMENT v3.22.0.1
Significant Accounting Policies - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Significant Accounting Policies [Abstract]      
Research and Development Expense $ 44,900 $ 40,000 $ 32,100
Cash and cash equivalents description The Company invests temporary and excess funds in money market securities and financial instruments having maturities within 90 days. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.    
Schedule Of Equity Method Investments [Line Items]      
Non-current deferred tax liabilities $ 179,025 192,763  
Retained earnings $ 516,334 $ 423,940  
Income Tax Examination Minimum Likelihood Of Tax Benefits Being Realized Upon Ultimate Settlement 50.00%